These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8009262)

  • 1. Effect of pamidronate on indices of bone turnover in Paget's disease followed for 6 years.
    Worsfold M; Sharp CA; Rowlands PR; Davie MW
    Semin Arthritis Rheum; 1994 Feb; 23(4):285. PubMed ID: 8009262
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of methods of assessing response of Paget's disease to bisphosphonate therapy.
    Patel S; Coupland CA; Stone MD; Hosking DJ
    Bone; 1995 Feb; 16(2):193-7. PubMed ID: 7756047
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of biochemical markers of bone turnover to pamidronate infusion in Paget's disease of bone.
    Sharp CA; Worsfold M; Rowlands PR; Davie MW
    Semin Arthritis Rheum; 1994 Feb; 23(4):242-3. PubMed ID: 8009239
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Paget's disease of bone with single dose intravenous pamidronate.
    Watts RA; Skingle SJ; Bhambhani MM; Pountain G; Crisp AJ
    Ann Rheum Dis; 1993 Aug; 52(8):616-8. PubMed ID: 8215628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term efficacy of intravenous pamidronate in Paget's disease of bone.
    Grauer A; Klar B; Scharla SH; Zieglar R
    Semin Arthritis Rheum; 1994 Feb; 23(4):283-4. PubMed ID: 8009261
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of intravenous pamidronate therapy on Paget's disease of bone.
    Bombassei GJ; Yocono M; Raisz LG
    Am J Med Sci; 1994 Oct; 308(4):226-33. PubMed ID: 7942981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bisphosphonate therapy of Paget's disease of bone with pamidronate].
    Grauer A; Klar B; Knaus J; Scharla SH; Ziegler R
    Med Klin (Munich); 1996 Jan; 91(1):14-9. PubMed ID: 8839196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Paget's disease of bone with single-dose intravenous pamidronate.
    Watts RA; Skingle S; Bhambani M; Pountain G; Crisp AJ
    Semin Arthritis Rheum; 1994 Feb; 23(4):281. PubMed ID: 8009259
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Paget's disease of bone.
    Anderson D; Cantrill JC
    Br Med J (Clin Res Ed); 1988 Jan; 296(6617):291. PubMed ID: 3124919
    [No Abstract]   [Full Text] [Related]  

  • 10. Prevention of appendicular bone loss in Paget's disease following treatment with intravenous pamidronate disodium.
    Stewart GO; Gutteridge DH; Price RI; Ward L; Retallack RW; Prince RL; Stuckey BG; Kent GN; Bhagat CI; Dhaliwal SS
    Bone; 1999 Feb; 24(2):139-44. PubMed ID: 9951784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mineralisation defects with pamidronate therapy for Paget's disease.
    Adamson BB; Gallacher SJ; Byars J; Ralston SH; Boyle IT; Boyce BF
    Lancet; 1993 Dec; 342(8885):1459-60. PubMed ID: 7902484
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative bone scintigraphy in the management of monostotic Paget's disease of bone.
    Patel S; Pearson D; Hosking DJ
    Arthritis Rheum; 1995 Oct; 38(10):1506-12. PubMed ID: 7575701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with pamidronate in the treatment of Paget's disease of bone.
    Gallacher SJ; Boyce BF; Patel U; Jenkins A; Ralston SH; Boyle IT
    Ann Rheum Dis; 1991 Dec; 50(12):930-3. PubMed ID: 1768163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pamidronate is effective for Paget's disease of bone refractory to conventional therapy.
    Wimalawansa SJ; Gunasekera RD
    Calcif Tissue Int; 1993 Oct; 53(4):237-41. PubMed ID: 8275351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravenous aminopropylidene bisphosphonate in the treatment of severe polyostotic Paget's disease of bone.
    Fritz P; Lioté F; Kuntz D
    Semin Arthritis Rheum; 1994 Feb; 23(4):282. PubMed ID: 8009260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Is beta 2-microglobulin a marker of bone remodeling in Paget's disease of bone?].
    Wilczek H
    Cas Lek Cesk; 1997 Dec; 136(23):730-2. PubMed ID: 9476376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moderate Paget's disease treated with pamidronate: comparison of various infusion rates for a 60-mg single dose.
    Thiebaud D; Portmann L; Burckhardt P
    Semin Arthritis Rheum; 1994 Feb; 23(4):279. PubMed ID: 8009257
    [No Abstract]   [Full Text] [Related]  

  • 18. Paget's disease--five years follow up after pamidronate therapy.
    Ryan PJ; Fogelman I
    Br J Rheumatol; 1994 Jan; 33(1):98-9. PubMed ID: 8162470
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of intravenous aminopropylidene bisphosphonate in patients with refractory Paget's disease.
    Cormier C; Hilliquin P; Menkès CJ
    Br J Rheumatol; 1993 Aug; 32(8):767-8. PubMed ID: 8348290
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of Paget's disease of bone with intravenous pamidronate: comparison of 2 different modes of treatment.
    Ismail AA; Fox P; Stamp TC; Dhillon V; Crisp AJ; MacGregor A
    J Rheumatol; 1997 Nov; 24(11):2266-7. PubMed ID: 9375899
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.